Peter Kies - 26 Feb 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: CFO
Signature: Peter Kies
Issuer symbol: INO
Transactions as of: 26 Feb 2023
Net transactions value: -$52,637
Form type: 4
Filing time: 28 Feb 2023, 16:42:00 UTC
Previous filing: 14 Mar 2022
Next filing: 13 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+22,544	+13%		201,828	26 Feb 2023	Direct	F1
transaction	INO	Common Stock	Tax liability	$16,548	-12,928	-6.4%	$1.28	188,900	26 Feb 2023	Direct	F2
transaction	INO	Common Stock	Options Exercise		+47,967	+25%		236,867	26 Feb 2023	Direct	F3
transaction	INO	Common Stock	Tax liability	$36,090	-28,195	-12%	$1.28	208,672	26 Feb 2023	Direct	F4
holding	INO	Common Stock						4,500	26 Feb 2023	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-22,544	-50%	$0.000000	22,544	26 Feb 2023	Common Stock	22,544		Direct	F1
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-47,967	-33%	$0.000000	95,933	26 Feb 2023	Common Stock	47,967		Direct	F3
transaction	INO	Common Stock Option	Award	$0	+225,000		$0.000000	225,000	27 Feb 2023	Common Stock	225,000	$1.24	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
F3	Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 143,900 restricted stock units, vesting as follows: 47,967 shares vested on February 26, 2023; 47,967 shares will vest on February 26, 2024; and 47,966 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F4	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein.
F5	The vesting schedule for the 225,000 options is as follows: 56,250 shares vested on February 27, 2023; 56,250 shares will vest on February 26, 2024; 56,250 shares will vest on February 26, 2025; and 56,250 shares will vest on February 26, 2026.